Navigation Links
Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox"
Date:3/1/2013

MIAMI LAKES, Fla., March 1, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce that CEO Brian Tuffin and Daymond John , CEO of Shark Branding, LLC and Shark Branding Corp. are scheduled to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox" today, March 1st, 2013."Taking Stock", hosted by Bloomberg Television anchor Pimm Fox, offers insight into company news, long-term strategy, trading tactics, market techniques, stocks, bonds, commodities and currencies and is broadcast weekdays at 5:00 pm EST.

A replay of the interview will be archived and available within the Investor Relations section of the Fuse Science, Inc. corporate web site: http://ir.stockpr.com/fusescience/overview shortly after the broadcast.About Shark Branding Corp.Shark Branding's team of expert communicators, strategic analysts, and creative heavyweights excels in transforming businesses into iconic brands.  At the helm is business and branding expert Daymond John , CEO and Founder of FUBU, a $6 billion global fashion game-changer.  Daymond's entrepreneurialism and trend-moving influence are key to the company's cultivation of great brands.  Putting products in the hands of influencers and trendsetters is Shark Branding's core practice. Shark Branding clients benefit from a 360 degree approach to the growth of a healthy, successful brand with services ranging from brand strategy, design, and licensing; event development; celebrity affiliation and media; digital marketing; and the fundamentals of business leadership.  For more information, visit: www.sharkbranding.com

About Fuse Science, Inc.Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse news as it happens, follow @Fuse_Science on Twitter and Like Us on Facebook HERE!For more information:To schedule an interview:Fuse Science, Inc.Gus DeQuesadaInvestor RelationsMichelsen AdvertisingDirect: (305) 503-3873, Ext. 2C-305-733-1410 / 786-488-7138Email: ir@fusescience.com

prnews@michelsenadvertising.comSafe Harbor StatementCertain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.


'/>"/>
SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
2. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
3. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
4. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
5. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
6. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
7. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
8. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
9. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
11. Tonicology LLC Partners with Taiwan's CGB, Corp. to Offer Pure Extracts of Rare Herbal Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
Breaking Biology News(10 mins):